D. Seshasayee, P. Valdez, Minhong Yan, V. Dixit, D. Tumas, I. Grewal (2003)
Loss of TACI causes fatal lymphoproliferation and autoimmunity, establishing TACI as an inhibitory BLyS receptor.Immunity, 18 2
D. Garrick, S. Fiering, David Martin, E. Whitelaw (1998)
Repeat-induced gene silencing in mammalsNature Genetics, 18
L. Schiffer, R. Bethunaickan, M. Ramanujam, W. Huang, M. Schiffer, H. Tao, M. Madaio, E. Bottinger, A. Davidson (2008)
Activated renal macrophages are markers of disease onset and disease remission in lupus nephritisThe Journal of Immunology, 180
M. Ramanujam, Xiaobo Wang, Wei-qing Huang, Zheng Liu, L. Schiffer, H. Tao, D. Frank, J. Rice, B. Diamond, Karl Yu, S. Porcelli, A. Davidson (2006)
Similarities and differences between selective and nonselective BAFF blockade in murine SLE.The Journal of clinical investigation, 116 3
R. Vollenhoven, O. Zamani, D. Wallace, D. Tegzová, J. Merrill, W. Chatham, A. Schwarting, F. Hiepe, A. Doria, J. Sánchez-Guerrero, S. Jeka, A. Dyczek, R. Furie, M. Petri, D. D'cruz, Z. Fojtík, L. Pineda, Z. Zhong, D. Hough, W. Freimuth, R. Cervera (2011)
BELIMUMAB, A BLYS-SPECIFIC INHIBITOR, REDUCES DISEASE ACTIVITY AND SEVERE FLARES IN SEROPOSITIVE SLE PATIENTSClinical and Experimental Rheumatology, 29
C. Jacob, Song Zang, Lily Li, V. Ciobanu, F. Quismorio, Akiei Mizutani, M. Satoh, M. Koss (2003)
Pivotal Role of Stat4 and Stat6 in the Pathogenesis of the Lupus-Like Disease in the New Zealand Mixed 2328 Mice 1The Journal of Immunology, 171
N. Jacob, Hai-tao Yang, L. Pricop, Yi Liu, Xiaoni Gao, S. Zheng, Juhua Wang, Hua-Xin Gao, C. Putterman, M. Koss, W. Stohl, C. Jacob (2009)
Accelerated Pathological and Clinical Nephritis in Systemic Lupus Erythematosus-Prone New Zealand Mixed 2328 Mice Doubly Deficient in TNF Receptor 1 and TNF Receptor 2 via a Th17-Associated Pathway1The Journal of Immunology, 182
S. Khare, I. Sarosi, X. Xia, Susan McCabe, K. Miner, I. Solovyev, N. Hawkins, M. Kelley, D. Chang, Gwyneth Van, Larry Ross, John Delaney, Ling Wang, D. Lacey, W. Boyle, H. Hsu (2000)
Severe B cell hyperplasia and autoimmune disease in TALL-1 transgenic mice.Proceedings of the National Academy of Sciences of the United States of America, 97 7
Geoffrey Hom, R. Graham, B. Modrek, K. Taylor, W. Ortmann, S. Garnier, Annette Lee, Sharon Chung, Ricardo Ferreira, P.V. Pant, D. Ballinger, R. Kosoy, F. Demirci, M. Kamboh, A. Kao, Chaoyong Tian, I. Gunnarsson, A. Bengtsson, S. Rantapää-Dahlqvist, M. Petri, S. Manzi, Michael Seldin, L. Rönnblom, A. Syvänen, L. Criswell, P. Gregersen, T. Behrens (2008)
Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX.The New England journal of medicine, 358 9
S. Santini, C. Lapenta, M. Logozzi, S. Parlato, M. Spada, T. Pucchio, F. Belardelli (2000)
Type I Interferon as a Powerful Adjuvant for Monocyte-Derived Dendritic Cell Development and Activity in Vitro and in Hu-Pbl-Scid MiceThe Journal of Experimental Medicine, 191
W. Stohl, Dong Xu, K. Kim, M. Koss, T. Jorgensen, B. Deocharan, T. Metzger, S. Bixler, Y. Hong, C. Ambrose, F. Mackay, L. Morel, C. Putterman, B. Kotzin, S. Kalled (2005)
BAFF overexpression and accelerated glomerular disease in mice with an incomplete genetic predisposition to systemic lupus erythematosus.Arthritis and rheumatism, 52 7
A. Sadanaga, H. Nakashima, M. Akahoshi, K. Masutani, K. Miyake, T. Igawa, N. Sugiyama, H. Niiro, M. Harada (2007)
Protection against autoimmune nephritis in MyD88-deficient MRL/lpr mice.Arthritis and rheumatism, 56 5
M. Shlomchik, M. Madaio, Donghui Ni, Mary Trounstein, D. Huszar (1994)
The role of B cells in lpr/lpr-induced autoimmunityThe Journal of Experimental Medicine, 180
F. Mackay, Stephen Woodcock, P. Lawton, C. Ambrose, M. Baetscher, P. Schneider, J. Tschopp, J. Browning (1999)
Mice Transgenic for Baff Develop Lymphocytic Disorders along with Autoimmune ManifestationsThe Journal of Experimental Medicine, 190
S. Chang, S. Mihalcik, D. Jelinek (2008)
B Lymphocyte Stimulator Regulates Adaptive Immune Responses by Directly Promoting Dendritic Cell Maturation1The Journal of Immunology, 180
R. Looney, J. Anolik, D. Campbell, R. Felgar, F. Young, L. Arend, J. Sloand, J. Rosenblatt, I. Sanz (2004)
B cell depletion as a novel treatment for systemic lupus erythematosus: a phase I/II dose-escalation trial of rituximab.Arthritis and rheumatism, 50 8
Navarra (2009)
Belimumab, a BLyS-specific inhibitor, reduced disease activity, flares and prednisone use in patients with active SLE: efficacy and safety results from the phase 3 BLISS-52 study.
I. Gunnarsson, B. Sundelin, T. Jónsdóttir, S. Jacobson, E. Henriksson, R. Vollenhoven (2007)
Histopathologic and clinical outcome of rituximab treatment in patients with cyclophosphamide-resistant proliferative lupus nephritis.Arthritis and rheumatism, 56 4
Manzi (2010)
Belimumab, a BLyS-specific inhibitor, reduced disease activity across multiple organ domains: combined efficacy results from the phase 3 BLISS-52 and -76 studies.
Hiroyuki Nishimura, M. Nose, H. Hiai, N. Minato, T. Honjo (1999)
Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor.Immunity, 11 2
R. Brummel, T. Roberts, K. Stacey, P. Lenert (2006)
Higher‐order CpG‐DNA stimulation reveals distinct activation requirements for marginal zone and follicular B cells in lupus miceEuropean Journal of Immunology, 36
D. Nacionales, K. Kelly-Scumpia, P. Lee, J. Weinstein, R. Lyons, E. Sobel, M. Satoh, W. Reeves (2007)
Deficiency of the type I interferon receptor protects mice from experimental lupus.Arthritis and rheumatism, 56 11
N. Kayagaki, Minhong Yan, D. Seshasayee, Hua Wang, Wyne Lee, D. French, I. Grewal, A. Cochran, N. Gordon, Jianping Yin, M. Starovasnik, V. Dixit (2002)
BAFF/BLyS receptor 3 binds the B cell survival factor BAFF ligand through a discrete surface loop and promotes processing of NF-kappaB2.Immunity, 17 4
Lynda Bennett, A. Palucka, E. Arce, E. Arce, Victoria Cantrell, Victoria Cantrell, J. Borvák, J. Banchereau, V. Pascual, V. Pascual (2003)
Interferon and Granulopoiesis Signatures in Systemic Lupus Erythematosus BloodThe Journal of Experimental Medicine, 197
A. Strasser, S. Whittingham, D. Vaux, M. Bath, Jerry Adams, S. Cory, A. Harris (1991)
Enforced BCL2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease.Proceedings of the National Academy of Sciences of the United States of America, 88 19
T. Niewold, W. Swedler (2005)
Systemic lupus erythematosus arising during interferon-alpha therapy for cryoglobulinemic vasculitis associated with hepatitis CClinical Rheumatology, 24
P. Markel, P. Shu, C. Ebeling, G. Carlson, D. Nagle, J. Smutko, K. Moore (1997)
Theoretical and empirical issues for marker-assisted breeding of congenic mouse strainsNature Genetics, 17
A. Yi, D. Klinman, T. Martin, S. Matson, A. Krieg (1996)
Rapid immune activation by CpG motifs in bacterial DNA. Systemic induction of IL-6 transcription through an antioxidant-sensitive pathway.Journal of immunology, 157 12
L. Ng, C. Ng, Blanche Woehl, Andrew Sutherland, J. Huo, Shengli Xu, F. Mackay, K. Lam (2006)
BAFF costimulation of Toll‐like receptor‐activatedB‐1 cellsEuropean Journal of Immunology, 36
Mikhail Litinskiy, B. Nardelli, D. Hilbert, B. He, A. Schaffer, P. Casali, A. Cerutti (2002)
DCs induce CD40-independent immunoglobulin class switching through BLyS and APRILNature Immunology, 3
Don Armstrong, Don Armstrong, A. Reiff, B. Myones, F. Quismorio, M. Klein-Gitelman, D. McCurdy, L. Wagner-Weiner, E. Silverman, J. Ojwang, K. Kaufman, J. Kelly, J. Merrill, J. Harley, S. Bae, T. Vyse, G. Gilkeson, P. Gaffney, K. Moser, C. Putterman, J. Edberg, E. Brown, J. Ziegler, C. Langefeld, R. Zidovetzki, C. Jacob (2009)
Identification of new SLE-associated genes with a two-step Bayesian study designGenes and Immunity, 10
Shizhong Han, X. KIM-HOWARD, Harshal Deshmukh, Y. Kamatani, Parvathi Viswanathan, J. Guthridge, Kenaz Thomas, K. Kaufman, J. Ojwang, A. Rojas-Villarraga, V. Baca, L. Orozco, B. Rhodes, Chan-Bum Choi, P. Gregersen, J. Merrill, J. James, P. Gaffney, K. Moser, C. Jacob, R. Kimberly, J. Harley, S. Bae, J. Anaya, M. Alarcón-Riquelme, K. Matsuda, T. Vyse, S. Nath (2009)
Evaluation of imputation-based association in and around the integrin-alpha-M (ITGAM) gene and replication of robust association between a non-synonymous functional variant within ITGAM and systemic lupus erythematosus (SLE).Human molecular genetics, 18 6
M. Botto, C. Agnola, A. Bygrave, E. Thompson, H. Cook, F. Petry, M. Loos, P. Pandolfi, M. Walport (1998)
Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodiesNature Genetics, 19
Furie (2010)
Belimumab, a BLyS-specific inhibitor, reduced disease activity and severe flares in seropositive SLE patients: BLISS-76 study results through wk 76.
Jonathan Hron, S. Peng (2004)
Type I IFN Protects Against Murine Lupus1The Journal of Immunology, 173
J. Gross, J. Johnston, S. Mudri, Rachel Enselman, S. Dillon, K. Madden, Wenfeng Xu, J. Parrish-Novak, D. Foster, C. Lofton-Day, M. Moore, A. Littau, A. Grossman, H. Haugen, K. Foley, H. Blumberg, K. Harrison, W. Kindsvogel, C. Clegg (2000)
TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune diseaseNature, 404
Emily Baechler, F. Batliwalla, G. Karypis, P. Gaffney, W. Ortmann, Karl Espe, Katherine Shark, William Grande, K. Hughes, V. Kapur, P. Gregersen, T. Behrens (2003)
Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupusProceedings of the National Academy of Sciences of the United States of America, 100
B. Deocharan, P. Marambio, M. Edelman, C. Putterman (2003)
Differential effects of interleukin-4 in peptide induced autoimmunity.Clinical immunology, 108 2
E. Remmers, R. Plenge, Annette Lee, R. Graham, Geoffrey Hom, T. Behrens, P. Bakker, J. Le, Hye-Soon Lee, F. Batliwalla, Wentian Li, S. Masters, M. Booty, J. Carulli, L. Padyukov, L. Alfredsson, L. Klareskog, W. Chen, C. Amos, L. Criswell, M. Seldin, D. Kastner, P. Gregersen (2007)
STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus.The New England journal of medicine, 357 10
U. Rudofsky, B. Evans, S. Balaban, Mottironi Vd, Gabrielsen Ae (1993)
Differences in expression of lupus nephritis in New Zealand mixed H-2z homozygous inbred strains of mice derived from New Zealand black and New Zealand white mice. Origins and initial characterization.Laboratory investigation; a journal of technical methods and pathology, 68 4
S. Bolland, J. Ravetch (2000)
Spontaneous autoimmune disease in Fc(gamma)RIIB-deficient mice results from strain-specific epistasis.Immunity, 13 2
Isabelle Berkeredjian-Ding, M. Wagner, V. Hornung, T. Giese, M. Schnurr, S. Endres, G. Hartmann (2005)
Plasmacytoid dendritic cells control TLR7 sensitivity of naive B cells via type I IFNThe Journal of Immunology, 174
C. Jacob, Jiankun Zhu, Don Armstrong, M. Yan, Jie Han, Xin Zhou, James Thomas, A. Reiff, B. Myones, J. Ojwang, K. Kaufman, M. Klein‐gitelman, D. McCurdy, L. Wagner-Weiner, E. Silverman, J. Ziegler, J. Kelly, J. Merrill, J. Harley, R. Ramsey‐Goldman, L. Vilá, S. Bae, T. Vyse, G. Gilkeson, P. Gaffney, K. Moser, C. Langefeld, R. Zidovetzki, C. Mohan (2009)
Identification of IRAK1 as a risk gene with critical role in the pathogenesis of systemic lupus erythematosusProceedings of the National Academy of Sciences, 106
T. Jónsdóttir, I. Gunnarsson, A. Risselada, E. Henriksson, Lars Klareskog, R. Vollenhoven (2007)
Treatment of refractory SLE with rituximab plus cyclophosphamide: clinical effects, serological changes, and predictors of responseAnnals of the Rheumatic Diseases, 67
L. Treml, G. Carlesso, K. Hoek, Jason Stadanlick, T. Kambayashi, R. Bram, M. Cancro, W. Khan (2007)
TLR Stimulation Modifies BLyS Receptor Expression in Follicular and Marginal Zone B Cells1The Journal of Immunology, 178
(2010)
BLISS-52 and -76
I. Bekeredjian-Ding, M. Wagner, V. Hornung, T. Giese, M. Schnurr, S. Endres, G. Hartmann (2005)
Plasmacytoid Dendritic Cells Control TLR7 Sensitivity of Naive B Cells via Type I IFN1The Journal of Immunology, 174
M. Santiago‐Raber, R. Baccala, Katarina Haraldsson, D. Choubey, T. Stewart, D. Kono, A. Theofilopoulos (2003)
Type-I Interferon Receptor Deficiency Reduces Lupus-like Disease in NZB MiceThe Journal of Experimental Medicine, 197
(2008)
International Consortium for Systemic Lupus Erythematosus Genetics (SLEGEN)
J. Harley, M. Alarcón-Riquelme, L. Criswell, C. Jacob, R. Kimberly, K. Moser, B. Tsao, T. Vyse, C. Langefeld (2008)
Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other lociNature Genetics, 40
M. Leandro, J. Edwards, G. Cambridge, M. Ehrenstein, D. Isenberg (2002)
An open study of B lymphocyte depletion in systemic lupus erythematosus.Arthritis and rheumatism, 46 10
B. Nardelli, O. Belvedere, V. Roschke, Paul Moore, Henrik Olsen, T. Migone, S. Sosnovtseva, J. Carrell, P. Feng, Judith Giri (2001)
Synthesis and release of B-lymphocyte stimulator from myeloid cells.Blood, 97 1
B. Finck, B. Chan, D. Wofsy (1994)
Interleukin 6 promotes murine lupus in NZB/NZW F1 mice.The Journal of clinical investigation, 94 2
Hemant Agrawal, N. Jacob, E. Carreras, Sandra Bajaña, C. Putterman, Sean Turner, B. Neas, A. Mathian, M. Koss, W. Stohl, S. Kovats, C. Jacob (2009)
Deficiency of Type I IFN Receptor in Lupus-Prone New Zealand Mixed 2328 Mice Decreases Dendritic Cell Numbers and Activation and Protects from Disease1The Journal of Immunology, 183
K. Kirou, Christina Lee, Sandhya George, Kyriakos Louca, Ioannis Papagiannis, M. Peterson, Ngoc Ly, R. Woodward, K. Fry, A. Lau, James Prentice, J. Wohlgemuth, M. Crow (2004)
Coordinate overexpression of interferon‐α–induced genes in systemic lupus erythematosusArthritis & Rheumatism, 50
M. Ramanujam, P. Kahn, Wei-qing Huang, H. Tao, M. Madaio, S. Factor, A. Davidson (2009)
Interferon-alpha treatment of female (NZW x BXSB)F(1) mice mimics some but not all features associated with the Yaa mutation.Arthritis and rheumatism, 60 4
Masahiko Mihara, Nobuhiro Takagi, Yasuhisa Takeda, Y. Ohsugi (1998)
IL‐6 receptor blockage inhibits the onset of autoimmune kidney disease in NZB/W F1 miceClinical & Experimental Immunology, 112
C. Jacob, L. Pricop, C. Putterman, M. Koss, Yi Liu, Maria Kollaros, S. Bixler, C. Ambrose, M. Scott, W. Stohl (2006)
Paucity of Clinical Disease despite Serological Autoimmunity and Kidney Pathology in Lupus-Prone New Zealand Mixed 2328 Mice Deficient in BAFF1The Journal of Immunology, 177
P. Sfikakis, J. Boletis, S. Lionaki, V. Vigklis, K. Fragiadaki, A. Iniotaki, H. Moutsopoulos (2005)
Remission of proliferative lupus nephritis following B cell depletion therapy is preceded by down-regulation of the T cell costimulatory molecule CD40 ligand: an open-label trial.Arthritis and rheumatism, 52 2
Zeguo Zhao, L. Burkly, S. Campbell, Noa Schwartz, A. Molano, A. Choudhury, R. Eisenberg, J. Michaelson, C. Putterman (2007)
TWEAK/Fn14 Interactions Are Instrumental in the Pathogenesis of Nephritis in the Chronic Graft-versus-Host Model of Systemic Lupus erythematosus1The Journal of Immunology, 179
(2010)
BLISS-76 Study Group
Ryan Webb, J. Merrill, J. Kelly, A. Sestak, K. Kaufman, C. Langefeld, J. Ziegler, R. Kimberly, J. Edberg, R. Ramsey‐Goldman, M. Petri, J. Reveille, G. Alarcón, L. Vilá, M. Alarcón-Riquelme, J. James, G. Gilkeson, C. Jacob, K. Moser, P. Gaffney, T. Vyse, S. Nath, P. Lipsky, J. Harley, A. Sawalha (2009)
A polymorphism within IL21R confers risk for systemic lupus erythematosus.Arthritis and rheumatism, 60 8
A. Krieg, A. Yi, S. Matson, T. Waldschmidt, G. Bishop, R. Teasdale, G. Koretzky, D. Klinman (1995)
CpG motifs in bacterial DNA trigger direct B-cell activationNature, 374
Donna Thibault, Kareem Graham, Lowen Lee, I. Balboni, P. Hertzog, P. Utz (2009)
Type I interferon receptor controls B-cell expression of nucleic acid-sensing Toll-like receptors and autoantibody production in a murine model of lupusArthritis Research & Therapy, 11
A. Cristofano, P. Kotsi, Y. Peng, C. Cordon-Cardo, K. Elkon, P. Pandolfi (1999)
Impaired Fas response and autoimmunity in Pten+/- mice.Science, 285 5436
B. Ryffel, B. Car, H. Gunn, D. Román, P. Hiestand, M. Mihatsch (1994)
Interleukin-6 exacerbates glomerulonephritis in (NZB x NZW)F1 mice.The American journal of pathology, 144 5
C. Jacob, A. Reiff, Don Armstrong, B. Myones, E. Silverman, M. Klein‐gitelman, D. McCurdy, L. Wagner-Weiner, J. Nocton, A. Solomon, R. Zidovetzki (2007)
Identification of novel susceptibility genes in childhood-onset systemic lupus erythematosus using a uniquely designed candidate gene pathway platform.Arthritis and rheumatism, 56 12
J. Groom, Carrie Fletcher, S. Walters, S. Grey, S. Watt, Mathew Sweet, M. Smyth, C. Mackay, F. Mackay (2007)
BAFF and MyD88 signals promote a lupuslike disease independent of T cellsThe Journal of Experimental Medicine, 204
P. Blanco, A. Palucka, M. Gill, M. Gill, V. Pascual, V. Pascual, J. Banchereau (2001)
Induction of Dendritic Cell Differentiation by IFN-α in Systemic Lupus ErythematosusScience, 294
A. Fairhurst, A. Mathian, John Connolly, Andrew Wang, Hillery Gray, T. George, Christopher Boudreaux, Xin Zhou, Quanzhen Li, S. Koutouzov, J. Banchereau, E. Wakeland (2008)
Systemic IFN‐α drives kidney nephritis in B6.Sle123 miceEuropean Journal of Immunology, 38
M. Ramanujam, Xiaobo Wang, Wei-qing Huang, L. Schiffer, C. Grimaldi, Alla Akkerman, B. Diamond, M. Madaio, A. Davidson (2004)
Mechanism of Action of Transmembrane Activator and Calcium Modulator Ligand Interactor-Ig in Murine Systemic Lupus Erythematosus1The Journal of Immunology, 173
D. Albert, Jonathan Dunham, Salar Khan, J. Stansberry, S. Kolasinski, D. Tsai, Sally Pullman-Mooar, F. Barnack, C. Striebich, R. Looney, E. Prak, Robert Kimberly, Y. Zhang, R. Eisenberg (2008)
Variability in the biological response to anti-CD20 B cell depletion in systemic lupus erythaematosusAnnals of the Rheumatic Diseases, 67
O. Chan, L. Hannum, A. Haberman, M. Madaio, M. Shlomchik (1999)
A Novel Mouse with B Cells but Lacking Serum Antibody Reveals an Antibody-independent Role for B Cells in Murine LupusThe Journal of Experimental Medicine, 189
L. Morel, Ying Yu, K. Blenman, R. Caldwell, E. Wakeland (1996)
Production of congenic mouse strains carrying genomic intervals containing SLE-susceptibility genes derived from the SLE-prone NZM2410 strainMammalian Genome, 7
R. Furie, M. Petri, Daniel Wallace, E. Ginzler, J. Merrill, W. Stohl, W. Chatham, V. Strand, A. Weinstein, M. Chevrier, Z. Zhong, W. Freimuth (2009)
Novel evidence-based systemic lupus erythematosus responder index.Arthritis and rheumatism, 61 9
Yihong Yao, L. Richman, B. Higgs, C. Morehouse, M. Reyes, P. Brohawn, Jianliang Zhang, B. White, A. Coyle, P. Kiener, B. Jallal (2009)
Neutralization of interferon-alpha/beta-inducible genes and downstream effect in a phase I trial of an anti-interferon-alpha monoclonal antibody in systemic lupus erythematosus.Arthritis and rheumatism, 60 6
Queenie Lam, Otis Ko, B. Zheng, Liwei Lu (2008)
Local BAFF gene silencing suppresses Th17-cell generation and ameliorates autoimmune arthritisProceedings of the National Academy of Sciences, 105
Samuel Waters, Shu Fu, F. Gaskin, U. Deshmukh, Sun-Sang Sung, C. Kannapell, Kenneth Tung, Sherri McEwen, Marcia McDuffie (2001)
NZM2328: a new mouse model of systemic lupus erythematosus with unique genetic susceptibility loci.Clinical immunology, 100 3
Daniel Wallace, W. Stohl, R. Furie, J. Lisse, J. McKay, J. Merrill, Michelle Petri, E. Ginzler, W. Chatham, W. McCune, Vivian Fernández, Marc Chevrier, Z. Zhong, W. Freimuth (2009)
A phase II, randomized, double-blind, placebo-controlled, dose-ranging study of belimumab in patients with active systemic lupus erythematosus.Arthritis and rheumatism, 61 9
S. Kariuki, K. Kirou, E. Macdermott, L. Barillas-arias, M. Crow, T. Niewold (2009)
Cutting Edge: Autoimmune Disease Risk Variant of STAT4 Confers Increased Sensitivity to IFN-α in Lupus Patients In Vivo1The Journal of Immunology, 182
A. Mathian, A. Weinberg, Mike Gallegos, J. Banchereau, S. Koutouzov (2005)
IFN-α Induces Early Lethal Lupus in Preautoimmune (New Zealand Black × New Zealand White)F1 but Not in BALB/c Mice1The Journal of Immunology, 174
The Journal of Immunology – Unpaywall
Published: Mar 7, 2011
Access the full text.
Sign up today, get DeepDyve free for 14 days.